Medaica

Medaica is a digital health company offering innovative solutions to enhance remote healthcare access and delivery. Their flagship product, the Medaica M1 Telehealth Stethoscope, is an FDA-cleared, patient-centric digital stethoscope designed for in-home use. Unlike traditional digital stethoscopes primarily designed for clinicians, the M1 is affordable, interoperable with existing telehealth systems, and does not require specific customization or integration.

In April 2023, Medaica announced a groundbreaking initiative to provide the M1 stethoscope free of cost to rural and underserved patients, addressing the critical shortage of healthcare access in these communities. Nearly 80% of rural America is medically underserved, with fewer than 40 physicians per 100,000 people, a problem compounded by an aging population and healthcare worker shortages. The M1 stethoscope aims to bridge this gap by enabling effective remote auscultation and examinations, reducing the burden on understaffed clinics.

Complementing the M1 stethoscope is Medaica Telehealth+, a comprehensive digital diagnostics and telehealth solution for healthcare providers. This platform integrates audio/video features, diagnostic tools, and the FDA-cleared M1 stethoscope, enabling healthcare professionals to monitor and examine remote patients as effectively as in-clinic visits.

In addition to its innovative products, Medaica pursues a mission-driven campaign titled "EveryBeatEveryBreath.org" to raise awareness and provide telehealth solutions with free stethoscopes to remote, underserved communities, and disadvantaged groups globally. Medaica is headquartered in Henderson, Nevada, with offices in London and Madrid.